|
|
||||||||||||||||||||||||||||
Taking aim at cancerNEW YORK (CNNfn) - A number of labs are working on experimental drugs that attack the causes of tumor growth, without harming the patient. One leading researcher says the developments could be the beginning of the end for chemotherapy.
Paul Raeburn, senior writer at Business Week, joins CNNfn's Bruce Francis and Patricia Sabga on The N.E.W. Show o get a closer look at promising new experimental cancer drugs. RELATED SITES:
|
BUSINESS Korea tops gains, BOJ gets new chief Japan taps Fukui as new BOJ chief Woolworths posts strong profit rise (MORE)
England beats South Africa in thrilling test match Greek PM says Athens will be safe, on time Russians struggle at world gymnastics
|
||||||||||||||||||||||||||||
| Back to the top |
© 2003 Cable News Network LP, LLLP.
A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Read our privacy guidelines. Contact us. |